| P50 | author | Dawn A Marcus | Q92185427 |
| P2093 | author name string | Joseph M Furman | |
| P2860 | cites work | Neurochemistry of the central vestibular pathways | Q72144622 |
| | Gender differences in motion sickness history and susceptibility to optokinetic rotation-induced motion sickness | Q73297027 |
| | Facial pain increases nausea and headache during motion sickness in migraine sufferers | Q75354244 |
| | Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia | Q77999849 |
| | Diagnosis of migrainous vertigo: validity of a structured interview | Q80009055 |
| | Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine | Q80131834 |
| | Neuro-otological findings in patients with migraine- and nonmigraine-related dizziness | Q80143312 |
| | Scopolamine for preventing and treating motion sickness | Q24246624 |
| | Physiological basis and pharmacology of motion sickness: an update | Q28138034 |
| | The International Classification of Headache Disorders: 2nd edition | Q29547231 |
| | Labyrinthine lesions and motion sickness susceptibility | Q30474040 |
| | Central nervous system abnormalities in migraine | Q30881385 |
| | Rizatriptan: an update of its use in the management of migraine | Q34136456 |
| | Brain stem activation in spontaneous human migraine attacks | Q34297421 |
| | Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin | Q34328951 |
| | Neural substrates linking balance control and anxiety | Q35044616 |
| | Rizatriptan in migraine | Q36257191 |
| | Motion sickness in migraine sufferers | Q36326249 |
| | Headaches related to triptans therapy in patients of migrainous vertigo | Q36332605 |
| | Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches | Q36360319 |
| | Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis | Q39414225 |
| | Blockade of motion- and cisplatin-induced emesis by a 5-HT2 receptor agonist in Suncus murinus | Q42076840 |
| | Migrainous vertigo: prevalence and impact on quality of life. | Q43711678 |
| | CNS effects of sumatriptan and rizatriptan in healthy female volunteers. | Q44051817 |
| | The effect of serotonin and serotonin receptor antagonists on motion sickness in Suncus murinus | Q44126721 |
| | Velocity storage activity is affected after sustained centrifugation: a relationship with spatial disorientation. | Q44408127 |
| | Episodic vertigo and migraine | Q46447434 |
| | Validation of a brief nurse-administered migraine assessment tool | Q46624449 |
| | Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study. | Q46862272 |
| | Migrainous vertigo: clinical, oculographic and posturographic findings | Q46902231 |
| | Serotonin-evoked modifications of the neuronal firing rate in the superior vestibular nucleus: a microiontophoretic study in the rat. | Q48336158 |
| | Neuro-otological manifestations of migraine | Q48597224 |
| | Rizatriptan has central antinociceptive effects against durally evoked responses | Q48685056 |
| | Triggers of motion sickness in migraine sufferers | Q50097195 |
| | Abnormalities of the vestibulo-collic reflex are similar in migraineurs with and without vertigo. | Q51952545 |
| | The interrelations of migraine, vertigo, and migrainous vertigo. | Q52966238 |
| | Vestibular function in migraine-related dizziness: a pilot study. | Q53001983 |
| | Vertigo, motion sickness and migraine | Q70944767 |
| | Diagnostic criteria for grading the severity of acute motion sickness | Q72042522 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | motion sickness | Q309067 |
| P304 | page(s) | 212-217 | |
| P577 | publication date | 2009-08-06 | |
| P1433 | published in | International Journal of Medical Sciences | Q10927439 |
| P1476 | title | A pilot study of rizatriptan and visually-induced motion sickness in migraineurs | |
| P478 | volume | 6 | |